Necessity of amoxicillin clavulanic acid in addition to prednisolone in mild-to-moderate COPD exacerbations

Marjolein Brusse-Keizer, Paul van der Valk, Ron Hendrix, Huib A.M. Kerstjens, Jacobus Adrianus Maria van der Palen

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Scopus)
69 Downloads (Pure)


Background: The effectiveness of antibiotics in chronic obstructive pulmonary disease (COPD) exacerbations is still a matter of debate, especially in outpatients with an intermediate probability of bacterial infection. Methods: In this study, 35 COPD outpatients diagnosed by their chest physician with moderately severe COPD exacerbation, but without pneumonia, were randomised in a double blind, placebo-controlled study. Patients had one or two of the following characteristics: a positive Gram's stain of the sputum, 2 or more exacerbations in the previous year, a decrease in lung function of >200 mL and >12%. Patients received amoxicillin clavulanic acid (500/125 mg three times daily) or placebo for 7 days, always combined with a course of prednisolone (30 mg/day) for 7 days. Primary outcome was duration of the exacerbation. Additionally, we measured severity of the exacerbation, health-related quality of life, sputum parameters, number of relapses within 28 days and the number of re-exacerbations within 4 months after the study. Results: There was no difference observed in time to resolution of the exacerbation between the two groups (HR=1.12; (95% CI 0.5 to 2.3; p=0.77)), nor in any other treatment parameter. Conclusions: We detected no evidence for the effectiveness of addition of antibiotics to prednisolone for COPD exacerbations of moderate severity and with intermediate probability of bacterial infection in this underpowered study. More placebo-controlled studies are needed to properly define subgroups of COPD outpatients in which antibiotics are of additional value.
Original languageEnglish
Article numbere000052
Pages (from-to)1-7
JournalBMJ open respiratory research
Issue number1
Publication statusPublished - 2014


  • METIS-308142
  • IR-93687


Dive into the research topics of 'Necessity of amoxicillin clavulanic acid in addition to prednisolone in mild-to-moderate COPD exacerbations'. Together they form a unique fingerprint.

Cite this